LTS has at its disposal exceptionally well-equipped research, development and production facilities covering all areas – from drug development to the production for the global market. Feasibility studies, technical and clinical development (up to phase II) of novel agents, drug delivery systems, production and quality control – LTS offers all this from a single source, tailored to individual customers’ requirements.
The expertise of our experienced pharmacists and engineers enables us to respond to the requirements of each and every customer. This results in customised production systems and facilities. In addition, LTS can react quickly and flexibly to new requirements in the global pharmaceuticals markets and adapt its production processes to comply with them.
Full-service partner for phases I to IV
LTS´ Clinical Research Services (CRS) is part of the LTS Group and has been conducting phase I and II clinical trials for over 35 years. The institute has 230 beds and a large medical department featuring leading-edge equipment for non-invasive analysis. With its highly qualified employees, CRS has everything it needs to successfully complete any clinical trial within the shortest possible time period. CRS also manages phase III and IV trials.
Tailored production facilities at two locations
One of LTS’s major strengths is its production expertise. From small- laboratory scale to fulfilling all the production requirements for sales on the global market – we provide our customers with what you need. From a pilot plant, our research department develops high-tech production facilities that can cope with global production to exacting laboratory specifications. If required, LTS can also construct with its engineering capabilities completely new production lines in order to realise new product designs, for example. Our practically identical production facilities in Europe and the US guarantee the highest degree of supply reliability and can be used interchangeably if required.
LTS can also manufacture everything it develops
A major advantage of working with LTS is its experience and reliability. Our diverse experience with active substances, products and manufacturing processes simplifies drug development and ensures we can provide cost-effective solutions. LTS does not sell products under its own-brand but focuses exclusively on research, development and production for its partners in the pharmaceutical industry. Integrated, one-stop solutions from LTS guarantee a seamless transition between the individual stages in the development project. Thanks to its extensive expertise, LTS can respond to every customer request and adapt its work to the results desired by the customer.
Five steps of success
- Step I: Theoretical tests and benchmarking
- Step II: Practical feasibility study, including prototypes
- Stufe III: Step III: Complete pharmaceutical development programme, including clinical trial
- Step IV: Creation of the production line or the adaptation of existing production facilities
- Step V: Production for its partners as contract manufacturer
CRS, Your Full-Service Provider for Clinical Trials in Phases I to IV
In addition to the development and manufacturing of high innovative dosage forms of active ingredients, LTS is also able to support you in the clinical development of products through services offered by the contract research organisation CRS, a member of the LTS company. Since the early 90’ies the CRS Clinical Research Services Andernach GmbH and its legacy companies are supporting clients of LTS to accelerate and improve clinical research activities.
CRS has almost 40 years of experience in working as a full-service provider in clinical trials (Phases I to IV) for a wide range of pharmaceutical, biotechnology and medical device companies and is realising 50 to 80 trials per year.
One speciality of CRS is the conduct of clinical trials with special routes of applications such as transdermal and transmucosal drug delivery. The majority of trials in healthy volunteers as well as in patients can be handled in-house by involving the own clinical pharmacology units. Today, CRS is represented by 8 locations in Germany including 6 CPUs with 300 beds and a central place for clinical development and surrounding services such as consultancy, project management, monitoring, clinical trial supply management, bioanalytics, clinical data management, biometrics and medical writing.
For more information, visit the CRS-Website!
For every partnership, LTS adapts its research and development, technological expertise and production capacity to the requirements and expectations of the client company.